Saul N Weingart

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Enhancing safety reporting in adult ambulatory oncology with a clinician champion: a practice innovation
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA saul
    J Nurs Care Qual 24:203-10. 2009
  2. ncbi Clinicians' assessments of electronic medication safety alerts in ambulatory care
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    Arch Intern Med 169:1627-32. 2009
  3. ncbi Patient-reported safety and quality of care in outpatient oncology
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
    Jt Comm J Qual Patient Saf 33:83-94. 2007
  4. ncbi Medication errors involving oral chemotherapy
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 116:2455-64. 2010
  5. ncbi Incidence of severe pain in newly diagnosed ambulatory patients with stage IV cancer
    Thomas Isaac
    Dana Farber Cancer Institute, Boston, MA, USA
    Pain Res Manag 17:347-52. 2012
  6. ncbi Hospitalized patients' participation and its impact on quality of care and patient safety
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Int J Qual Health Care 23:269-77. 2011
  7. ncbi An empirical model to estimate the potential impact of medication safety alerts on patient safety, health care utilization, and cost in ambulatory care
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    Arch Intern Med 169:1465-73. 2009
  8. ncbi Can we rely on patients' reports of adverse events?
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, The Heller School for Social Policy and Management, Brandeis University, Boston, MA 02215 5450, USA
    Med Care 49:948-55. 2011
  9. ncbi A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02215 5450, USA
    Cancer 118:6278-86. 2012
  10. ncbi What constitutes patient safety culture in Chinese hospitals?
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02215 5450, USA
    Int J Qual Health Care 24:250-7. 2012

Detail Information

Publications24

  1. ncbi Enhancing safety reporting in adult ambulatory oncology with a clinician champion: a practice innovation
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA saul
    J Nurs Care Qual 24:203-10. 2009
    ..By identifying errors and worrisome conditions, it may help managers identify problems before they lead to harm...
  2. ncbi Clinicians' assessments of electronic medication safety alerts in ambulatory care
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    Arch Intern Med 169:1627-32. 2009
    ..We undertook a study of respondents' satisfaction with e-prescribing systems, their perceptions of alerts, and their perceptions of behavior changes resulting from alerts...
  3. ncbi Patient-reported safety and quality of care in outpatient oncology
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
    Jt Comm J Qual Patient Saf 33:83-94. 2007
    ..Although patients suffer the effects of medical errors and iatrogenic injuries, little is known about their ability to recognize these events in ambulatory specialty care...
  4. ncbi Medication errors involving oral chemotherapy
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 116:2455-64. 2010
    ..Given the expanding use of oral chemotherapies, the authors set out to examine errors in the prescribing, dispensing, administration, and monitoring of these drugs...
  5. ncbi Incidence of severe pain in newly diagnosed ambulatory patients with stage IV cancer
    Thomas Isaac
    Dana Farber Cancer Institute, Boston, MA, USA
    Pain Res Manag 17:347-52. 2012
    ..Pain is common among cancer patients...
  6. ncbi Hospitalized patients' participation and its impact on quality of care and patient safety
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Int J Qual Health Care 23:269-77. 2011
    ..To understand the extent to which hospitalized patients participate in their care, and the association of patient participation with quality of care and patient safety...
  7. ncbi An empirical model to estimate the potential impact of medication safety alerts on patient safety, health care utilization, and cost in ambulatory care
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    Arch Intern Med 169:1465-73. 2009
    ..Because ambulatory care clinicians override as many as 91% of drug interaction alerts, the potential benefit of electronic prescribing (e-prescribing) with decision support is uncertain...
  8. ncbi Can we rely on patients' reports of adverse events?
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, The Heller School for Social Policy and Management, Brandeis University, Boston, MA 02215 5450, USA
    Med Care 49:948-55. 2011
    ..Evidence suggests that patients can report a variety of adverse events (AEs) not captured by traditional methods such as a chart review. Little is known, however, about whether patient reports are useful for measuring patient safety...
  9. ncbi A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02215 5450, USA
    Cancer 118:6278-86. 2012
    ....
  10. ncbi What constitutes patient safety culture in Chinese hospitals?
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02215 5450, USA
    Int J Qual Health Care 24:250-7. 2012
    ....
  11. ncbi Rating recommendations for consumers about patient safety: sense, common sense, or nonsense?
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
    Jt Comm J Qual Patient Saf 35:206-15. 2009
    ..Although many organizations offer advice about the consumer's role in improving patient safety, little is known about these recommendations...
  12. ncbi The You CAN campaign: teamwork training for patients and families in ambulatory oncology
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
    Jt Comm J Qual Patient Saf 35:63-71. 2009
    ..DISCUSSION: A training program for patients and their families is feasible in ambulatory oncology and may be applicable to other clinical settings...
  13. ncbi Assessing the quality of pain care in ambulatory patients with advanced stage cancer
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
    J Pain Symptom Manage 43:1072-81. 2012
    ..Pain is common among patients with advanced cancer despite the dissemination of clinical pain care guidelines...
  14. ncbi US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards
    Saul N Weingart
    Dana Farber Cancer Institute, Boston, MA
    J Oncol Pract 8:7-12. 2012
    ..We sought to assess the implementation status of the ASCO/ONS chemotherapy administration safety standards...
  15. ncbi Assessing the value of electronic prescribing in ambulatory care: a focus group study
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Int J Med Inform 78:571-8. 2009
    ..We sought to understand the reasons for adoption and use of e-prescribing, as well as clinicians' complaints about and perceived benefits of drug allergy and interaction alerts...
  16. ncbi Electronic drug interaction alerts in ambulatory care: the value and acceptance of high-value alerts in US medical practices as assessed by an expert clinical panel
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA, USA
    Drug Saf 34:587-93. 2011
    ..Computerized physician order entry systems are known to improve patient safety in acute-care hospitals. However, as clinicians frequently override drug interaction and allergy alerts, their value in ambulatory care remains uncertain...
  17. ncbi Medication reconciliation in ambulatory oncology
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
    Jt Comm J Qual Patient Saf 33:750-7. 2007
    ..Few models for medication reconciliation in ambulatory primary or specialty care have been described, perhaps because of the special challenges posed by this environment...
  18. ncbi Process of care failures in breast cancer diagnosis
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, 44 Binney St, Boston, MA, 02115, USA
    J Gen Intern Med 24:702-9. 2009
    ..Process of care failures may contribute to diagnostic errors in breast cancer care...
  19. ncbi Medication safety messages for patients via the web portal: the MedCheck intervention
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Int J Med Inform 77:161-8. 2008
    ..Accordingly, the goal of this study was to learn whether electronic medication safety messages directed to patients can improve communication about medications and identify ADEs...
  20. ncbi Identifying women at risk of delayed breast cancer diagnosis
    Sherri O Stuver
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
    Jt Comm J Qual Patient Saf 37:568-75. 2011
    ..Delays in breast cancer diagnosis contribute to increased morbidity and mortality. Factors related to the occurrence of delayed diagnosis have not been well studied...
  21. ncbi Medication safety of five oral chemotherapies: a proactive risk assessment
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA
    J Oncol Pract 7:2-6. 2011
    ..Oral chemotherapies represent an emerging risk area in ambulatory oncology practice. To examine the hazards associated with five oral chemotherapies, we performed a proactive risk assessment...
  22. ncbi Comparing patient-reported hospital adverse events with medical record review: do patients know something that hospitals do not?
    Joel S Weissman
    Institute for Health Policy, Massachusetts General Hospital, Harvard School of Public Health, Dana Farber Cancer Institute, Boston, Massachusetts, USA
    Ann Intern Med 149:100-8. 2008
    ..Hospitals routinely survey patients about the quality of care they receive, but little is known about whether patient interviews can detect adverse events that medical record reviews do not...
  23. ncbi Oral chemotherapy safety practices at US cancer centres: questionnaire survey
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02115, USA
    BMJ 334:407. 2007
    ..To characterise current safety practices for the use of oral chemotherapy...
  24. ncbi Patient-reported service quality on a medicine unit
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Int J Qual Health Care 18:95-101. 2006
    ..Most studies rely on retrospective consumer surveys rather then more intensive data collection methods, possibly underestimating the incidence of service quality incidents...